http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104490934-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-704 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-337 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-704 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-337 |
| filingDate | 2014-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104490934-B |
| titleOfInvention | A kind of medical composition and its use |
| abstract | The application provides a kind of pharmaceutical composition, Crocodile choline of the described pharmaceutical composition comprising specific administration concentration and adriamycin or taxol.Described pharmaceutical composition can increase the type of the drug for oncotherapy, reduce drug resistance；And, due to there is synergistic effect between the Crocodile choline under specific administration dosage and chemotherapeutics (adriamycin or taxol), therefore it can significantly increase antitumor action, the dosage of one or two kinds of drugs can be reduced simultaneously, to have the function that attenuation, facilitate the compliance for enhancing patient. |
| priorityDate | 2014-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 50.